Immatics (IMTX) Current Taxes (2024 - 2025)
Immatics (IMTX) reported Current Taxes of $37249.4 for Q4 2025, down 98.02% on a YoY basis from $1.9 million in Q4 2024, and down 98.02% sequentially from $1.9 million in Q4 2024.
Immatics (IMTX) Current Taxes (2024 - 2025) Analysis & Trends
Immatics (IMTX) has 2 years of Current Taxes data on file, last reported at $37249.4 in Q4 2025.
- For the quarter ending Q4 2025, Current Taxes fell 98.02% year-over-year to $37249.4; the trailing twelve-month figure through Dec 2025 stood at $37249.4 (down 98.02% YoY), and the FY2025 full-year result was $36154.0, down 98.1% from the prior year.
- Current Taxes slipped to $37249.4 in Q4 2025, from $1.9 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $1.9 million in Q4 2024 to a low of $37249.4 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 63.52 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | 37,249.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37,249.39 |
| Dec 31, 2024 | 1.88 Mn |